News

Drug discovery company using machine learning raises $68M | Health IT

By December 22, 2022No Comments

Enveda Biosciences, a drug discovery platform and biotech company, raised $68 million in a series B funding round and debt financing agreement.

Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Drug discovery company using machine learning raises $68M | Health IT

Tags:

Previous PostPublic Education Campaign on Access to Reproductive Health Care | HHS Blog Posts

Next PostClop ransomware group targeting medical images | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us